EA200100515A3 - Диазепиноиндолы для лечения хронического обструктивного заболевания легких - Google Patents

Диазепиноиндолы для лечения хронического обструктивного заболевания легких

Info

Publication number
EA200100515A3
EA200100515A3 EA200100515A EA200100515A EA200100515A3 EA 200100515 A3 EA200100515 A3 EA 200100515A3 EA 200100515 A EA200100515 A EA 200100515A EA 200100515 A EA200100515 A EA 200100515A EA 200100515 A3 EA200100515 A3 EA 200100515A3
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
chronic obstructive
diazepinoindols
lung diseases
obstructive lung
Prior art date
Application number
EA200100515A
Other languages
English (en)
Other versions
EA200100515A2 (ru
Inventor
Аннетт Доуэрти
Original Assignee
Уорнер-Ламберт Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уорнер-Ламберт Компани filed Critical Уорнер-Ламберт Компани
Publication of EA200100515A2 publication Critical patent/EA200100515A2/ru
Publication of EA200100515A3 publication Critical patent/EA200100515A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Настоящее изобретение относится к применению диазепиноиндолов формулыв которой А представляет собой азотсодержащий гетероарил, а В представляет собой гидроксильный или аминорадикал, для лечения хронического обструктивного заболевания легких.
EA200100515A 2000-06-09 2001-06-06 Диазепиноиндолы для лечения хронического обструктивного заболевания легких EA200100515A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00401646A EP1161949A1 (en) 2000-06-09 2000-06-09 Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease

Publications (2)

Publication Number Publication Date
EA200100515A2 EA200100515A2 (ru) 2001-12-24
EA200100515A3 true EA200100515A3 (ru) 2002-06-27

Family

ID=8173724

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100515A EA200100515A3 (ru) 2000-06-09 2001-06-06 Диазепиноиндолы для лечения хронического обструктивного заболевания легких

Country Status (19)

Country Link
US (1) US6544983B2 (ru)
EP (1) EP1161949A1 (ru)
JP (1) JP2002138090A (ru)
KR (1) KR20010111457A (ru)
CN (1) CN1345725A (ru)
AR (1) AR030291A1 (ru)
AU (1) AU5181301A (ru)
BR (1) BR0102289A (ru)
CA (1) CA2347337A1 (ru)
CZ (1) CZ20011999A3 (ru)
EA (1) EA200100515A3 (ru)
HU (1) HUP0102388A3 (ru)
IL (1) IL143636A0 (ru)
MX (1) MXPA01005726A (ru)
NO (1) NO20012831L (ru)
NZ (1) NZ512222A (ru)
PL (1) PL347922A1 (ru)
SK (1) SK7832001A3 (ru)
ZA (1) ZA200104616B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
CA2544322C (en) * 2003-11-20 2012-05-08 Astellas Pharma Inc. Agent for treating chronic pelvic pain syndrome
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
KR20090045233A (ko) 2006-07-10 2009-05-07 파이온 유케이 리미티드 속효형 벤조디아제핀 염 및 이의 중합체 형태
US8426673B2 (en) 2008-01-11 2013-04-23 Astellas Pharma, Inc. Pathological animal model for pelvic pain syndrome
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
US20150148338A1 (en) * 2012-05-22 2015-05-28 Paion Uk Limited Compositions comprising short-acting benzodiazepines
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2652352A1 (fr) 1989-09-28 1991-03-29 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique.
FR2725719B1 (fr) 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv
FR2746800B1 (fr) * 1996-03-29 1998-06-05 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases 4
FR2762841B1 (fr) 1997-04-30 1999-07-02 Jouveinal Inst Rech Diazepino-indolones inhibitrices de phosphodiesterases iv

Also Published As

Publication number Publication date
EA200100515A2 (ru) 2001-12-24
AR030291A1 (es) 2003-08-20
US6544983B2 (en) 2003-04-08
SK7832001A3 (en) 2002-05-09
IL143636A0 (en) 2002-04-21
KR20010111457A (ko) 2001-12-19
JP2002138090A (ja) 2002-05-14
CA2347337A1 (en) 2001-12-09
MXPA01005726A (es) 2003-08-20
NZ512222A (en) 2002-10-25
CZ20011999A3 (cs) 2002-04-17
NO20012831D0 (no) 2001-06-08
HUP0102388A2 (hu) 2002-04-29
ZA200104616B (en) 2002-10-30
PL347922A1 (en) 2001-12-17
BR0102289A (pt) 2002-03-12
HU0102388D0 (en) 2001-08-28
AU5181301A (en) 2001-12-13
NO20012831L (no) 2001-12-10
US20020010175A1 (en) 2002-01-24
EP1161949A1 (en) 2001-12-12
CN1345725A (zh) 2002-04-24
HUP0102388A3 (en) 2004-11-29

Similar Documents

Publication Publication Date Title
NO2017022I1 (no) Obeticholinsyre
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
WO2002002506A8 (en) Compounds to treat alzheimer's disease
EA200401114A2 (ru) Замещённые гидроксиэтиламины
ATE430569T1 (de) Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung
CY1112932T1 (el) Αναστολεις sμαd7 για τη θεραπευτικη αγωγη ασθενειων του κνς
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
PA8537901A1 (es) Derivados de eteres utiles como agentes inhibidores de las isozimas pde4
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
WO2002002520A8 (en) Compounds to treat alzheimer's disease
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
BRPI0411900A (pt) compostos antivirais e métodos
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
SE0100172D0 (sv) New inhibitors against galectins
EA200100515A3 (ru) Диазепиноиндолы для лечения хронического обструктивного заболевания легких
EA200701181A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
SE0101082D0 (sv) Novel use
DE60231611D1 (de) Verabreichung von opioiden durch inhalation
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
MXPA04005809A (es) Inhibidores de proteinas quinasas.
SE0004101D0 (sv) New use
SE0002739D0 (sv) New use
SE0004827D0 (sv) Therapeutic compounds
ATE323505T1 (de) Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen